Vulnerable Covid patients to be given GSK's antibody drug on the NHS that can fight Omicron

Xevudy, made by British pharmaceutical giant GlaxoSmithKline, was shown to slash the risk of hospitalisation and death by 79 per cent in clinical trials.

from Health News | Mail Online https://ift.tt/3GYUvuf